RenovoRx, Inc. (RNXT) stock
RNXTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.04+0.09 (+8.91%)
Close on Nov 17, 2026Market cap $46.93MP/E –Yield –
RenovoRx market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
RenovoRx's market cap was $55.05M on Nov 11, 2026, against $33.62M a year earlier. Over the last 5 years it ranged from $6.84M to $87.09M, with a median of $25.41M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $55.05M | +78.8% |
| 2025 | Dec 31, 2025 | $30.79M | -0.6% |
| 2024 | Dec 31, 2024 | $30.96M | +26.4% |
| 2023 | Dec 29, 2023 | $24.49M | +14.9% |
| 2022 | Dec 30, 2022 | $21.32M | -50.6% |
| 2021 | Dec 31, 2021 | $43.12M | – |
See a number that looks wrong?